The Wisconsin State Journal highlighted Foley’s history and connection to Wisconsin in a feature commemorating the firm’s 175th anniversary.
Noting how the firm’s practices have expanded over the years from representing clients in agriculture, railroads and banking to cybersecurity and autonomous vehicles, Chairman and CEO Jay Rothman said that adaptability to an evolving economy is one of the main reasons that Foley has survived for 175 years. “We have to be as innovative as our clients are to be successful,” Rothman said. “No question about it.”
Rothman also pointed out that the firm’s success over the past 175 years is “due to our clients who have supported us and put their trust in us. It’s both an honor and humbling at the same time.”
Read the full story here.
Noting how the firm’s practices have expanded over the years from representing clients in agriculture, railroads and banking to cybersecurity and autonomous vehicles, Chairman and CEO Jay Rothman said that adaptability to an evolving economy is one of the main reasons that Foley has survived for 175 years. “We have to be as innovative as our clients are to be successful,” Rothman said. “No question about it.”
Rothman also pointed out that the firm’s success over the past 175 years is “due to our clients who have supported us and put their trust in us. It’s both an honor and humbling at the same time.”
Read the full story here.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”